Jespers L, Van Herzeele N, Lijnen H R, Van Hoef B, De Maeyer M, Collen D, Lasters I
Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, and Center for Molecular and Vascular Biology, KULeuven, Leuven, Belgium.
Biochemistry. 1998 May 5;37(18):6380-6. doi: 10.1021/bi972807i.
Staphylokinase (Sak), a 16-kDa bacterial protein, forms a 1:1 stoichiometric complex with the serine proteinase domain of human plasmin, which in turn converts other plasminogen molecules into plasmin. To identify amino acid residues critical for generating the Sak:plasmin activator complex, alanine-scanning mutagenesis was performed on phage-displayed micro-plasminogen (microPlg). Substitution of Arg719 with Ala [microPlg(R719A)] disrupted complex formation, although the sensitivity of phage-displayed microPlg(R719A) to activation by urokinase and the amidolytic activity of the micro-plasmin derivative [microPli(R719A)] remained unaffected. Likewise, the soluble microPlg(R719A) molecule did not generate a functional activator complex with Sak, whereas quantitative activation into plasmin was obtained upon incubation with either urokinase or the Sak:plasmin complex. Real-time biospecific affinity measurements revealed that the Arg --> Ala substitution at position 719 increased the equilibrium dissociation constant between microPlg(R719A) and Sak from 46 nM to 1 microM, primarily by reducing the association rate constant. Arg719 has recently also been implied in the functional complex formation between human plasmin and streptokinase [Dawson, K. M., Marshall, J. M., Raper, R. H., Gilbert, R. J., and Ponting, C. P. (1994) Biochemistry 33, 12042-12047.], suggesting that both bacterial cofactors may share common structural and/or mechanistic aspects for plasminogen activation.
葡萄球菌激酶(Sak)是一种16 kDa的细菌蛋白,它与人纤溶酶的丝氨酸蛋白酶结构域形成化学计量比为1:1的复合物,进而将其他纤溶酶原分子转化为纤溶酶。为了确定对于形成Sak:纤溶酶激活剂复合物至关重要的氨基酸残基,对噬菌体展示的微型纤溶酶原(microPlg)进行了丙氨酸扫描诱变。用丙氨酸取代Arg719 [microPlg(R719A)] 破坏了复合物的形成,尽管噬菌体展示的microPlg(R719A) 对尿激酶激活的敏感性以及微型纤溶酶衍生物 [microPli(R719A)] 的酰胺水解活性未受影响。同样,可溶性microPlg(R719A) 分子未与Sak形成功能性激活剂复合物,而与尿激酶或Sak:纤溶酶复合物孵育后可实现向纤溶酶的定量激活。实时生物特异性亲和力测量表明,719位的Arg→Ala取代使microPlg(R719A) 与Sak之间的平衡解离常数从46 nM增加到1 μM,主要是通过降低结合速率常数。最近,Arg719也被认为参与了人纤溶酶与链激酶之间的功能性复合物形成 [Dawson, K. M., Marshall, J. M., Raper, R. H., Gilbert, R. J., and Ponting, C. P. (1994) Biochemistry 33, 12042 - 12047.],这表明两种细菌辅因子在纤溶酶原激活方面可能具有共同的结构和/或机制。